Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.03
0% from low
Exchange
OTC Link
CS
Borrow rate
10.23%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Revenue | $2.2M | $2.8M | $8.5M | $17.3M | $3.0M | $7.2M | $20.2M |
| Cost of revenue | $7.5M | $9.2M | $15.9M | $32.9M | $31.9M | $10.3M | $19.1M |
| Gross profit | −$5.3M | −$6.4M | −$7.4M | −$15.7M | −$1.9M | −$3.1M | $1.0M |
| Gross margin | -246.7% | -225.9% | -87.7% | -90.7% | -63.0% | -43.8% | 5.0% |
| R&D | $19.1M | $38.0M | $33.5M | $36.7M | $28.2M | $3.5M | $0 |
| Operating income | −$37.8M | −$72.6M | −$91.3M | −$115.9M | −$23.0M | −$14.4M | −$57.0K |
| EBITDA | −$40.6M | −$71.6M | −$92.5M | −$105.1M | $35.2M | −$5.3M | $2.2M |
| Net income | −$47.9M | −$97.0M | −$102.0M | −$117.7M | −$39.6M | −$81.7M | −$9.5M |
| Net margin | -2211.8% | -3421.7% | -1204.9% | -681.7% | -1307.0% | -1139.9% | -47.4% |
| EPS (diluted) | -1.75 | -3.54 | -8.94 | -4.11 | -1.39 | -2.81 | -0.32 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $99M | $-1.35 | $-1.35–$-1.35 | 1 |
| 2027 | $163M | $-0.60 | $-0.60–$-0.60 | 1 |
Forward consensus · source: Financial Modeling Prep
ACUTUS MEDICAL INC
No one on the platform currently holds AFIB.
No tracked institution reports a position in AFIB as of their last filing.
No one on the platform has traded AFIB yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× sales vs its 7.5× historical median P/S.
Fair value ≈ $1.11 · price $0.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Fundamental analysis of $AFIB (Acutus Medical, Inc.) based on financial data and reported results. #AFIB
View on StockTwits ↗$AFIB Acutus Medical, Inc. (AFIB) remains an active corporate entity on the books of the State of Delaware. It has not legally ceased to exist, nor has it filed a final Certificate of Dissolution with the state.
View on StockTwits ↗$AFIB How Retail Shareholders Fight Back If a dark company is stripping the remaining value of the corporate shell via insider share printing, retail investors generally have two avenues of recourse: Derivative Lawsuits: Shareholders can band together to sue the individual board member and Deerfield in the Delaware Court of Chancery. The lawsuit would argue that the insider used inside information and board control to self-deal, diluting common equity to zero before the 2027 contract payout can distribute. SEC Whistleblower / Enforcement: If the share issuances are completely unrecorded, violating Section 16 (Form 4 reporting rules), a formal complaint to the SEC's micro-cap fraud division can trigger an investigation. The SEC can issue a "Cease and Desist," claw back the illicitly issued shares, and bar the CEO/insider from ever serving as an officer or director of a public company again. Deerfiled is walking on thin Ice!
View on StockTwits ↗$AFIB Part one: What Triggers Personal Liability? (Delaware Law) Because AFIB is incorporated in Delaware, its board members are bound by Delaware General Corporation Law. If a board member uses their insider position to enrich their own fund at the expense of retail shareholders, they cannot hide behind standard corporate protections. If sued by shareholders, the court applies a strict legal standard called "Entire Fairness." Shifted Burden of Proof Normally, courts give board members the benefit of the doubt (the Business Judgment Rule). But when a controlling lender has a man on the board and gets special share issuances, the court throws that out. The board member and Deerfield must prove to a judge that: Fair Dealing: The negotiation was completely honest, transparent, and not coerced. Fair Price: The number of shares given to the lender was economically fair to the existing shareholders and not a cheap, dilutive cash-grab.
View on StockTwits ↗$AFIB The Conflict of Interest: Two Hats, One Room When a Deerfield executive sits on the AFIB board, they owe a strict fiduciary duty of loyalty and care to AFIB’s common shareholders. They are legally required to act in the best interest of the company and its equity holders. However, as a lender (Deerfield), their primary goal is to get their debt repaid or to acquire assets at the lowest possible cost. When AFIB issues new shares or warrants to Deerfield to satisfy debt covenants or to avoid defaulting, the insider is effectively sitting on both sides of the transaction. They are the lender taking the shares, and they are the board member approving the share issuance.
View on StockTwits ↗$AFIB WHITE COLOR CRIMINALS, Are generally very smart people and Like to hide behind the paper work. To cover their tushy, They will file a 10-k sooner or later. The number of shares trading on daily Bases points to the FINAL CHAPTER Being written soon. "CRIMINALS" WHITE or otherwise, Smart or dumb, Always leave a trail behind, Hence why They get cought!! Every time, all the time.
View on StockTwits ↗$AFIB Can they hide it forever? Not really. While they can hide it from the OTC website, they cannot hide it from: The SEC: If they are still technically a "reporting" company, the share count must eventually appear in a 10-K or 10-Q. Subpoenas: In a bankruptcy or fraud investigation, the transfer agent is legally required to hand over the "Certified Shareholders List" to the court or regulators. Because in the past reporting they had mentioned that after the company has Wind down the opperation, They will distribute the CACH left to share holders, They are personaly responsible! Personal Liability: If the directors just "walk away" without a formal wind-down (including a final share accounting), they can be held personally liable for "breach of fiduciary duty." Paying the transfer agent is their "get out of jail free" card to show they handled the closure professionally. I dont think that they are stupid enough To just walk away!
View on StockTwits ↗$AFIB The management are paying the transfer agent, but preventing the TA from Reprting to OTC Site. That is legal. How do I know this! It has been months since the TA updated The share count, If they were not paying the TA, We would have seen a Caveat Emptor Sign on OTC site by now! Why would a company do this? If they are still paying the TA but hiding the data, it’s usually for one of these strategic (and often "dark") reasons: Hiding Dilution: The company may be issuing millions of new shares to pay off debt (toxic notes) and doesn't want the market to see the "O/S" (Outstanding Shares) skyrocketing until the selling is finished. Pending "Dark" Merger: They might be cleaning up the share structure for a private buyer and don't want speculators to see the share movements during negotiations. Hostility to Shareholders: If the management is in a legal battle with shareholders, they may cut off information flow to reduce the "tools" shareholders have to fight them in court.
View on StockTwits ↗$STXS that brief spike after earnings looks like a few shorts who covered because david was being honest about underperforming and now the selling is all the longs who given up on this. The only thing that remains is the potential of making this happen and for most people they will be smarter to wait and see if he can make it happen before they assume it will happen. In a nutshell it is a gamble at this point and nobody can take credit for saying they were smart for buying at these levels when nobody not even david is certain he could pull this off. Interestingly enough both ceo's of $AFIB and $STXS were named david. This time it looks like golliath is beating them down.
View on StockTwits ↗@trigger_finger @Eddypgil good thing you mentioned the nvidia program. You are correct those programs are nothing but press fluff nvidia does to give customers a chance to highlight their interest to buy their products. Same thing i unfortunately seeded a startup fintech a few years back one of the scammer founders told me they were part of the nvidia scholarship grant and was awarded 500k in their program which was nothing but 500k worth of credits matched to a spend purchase commitment. The fact a public company is spinning a similar sales spin is concerning to say the least. Back to the cath manufacturing, when i was invested in $AFIB they were able to build their own manufacturing team in 1 year to get a team to build 100mil worth of caths annually. Just ask david roman the ceo. Why stereotaxis didnt buy their assets makes me wonder what's really going on.
View on StockTwits ↗$AFIB This what I and a few share holder waiting to file, Their next 10K better be Very very very clean! A CLASS ACTION WILL BRING THEM TO THE TABLE! DEERFIELD IS NOT EXCLUDED, SINCE THEY HAVE A BOARD MEMBER. IT'S CALLED; Fiduciary Duties Even if a company is "dark" and on the Expert Market, the Board of Directors still owes a fiduciary duty to all shareholders. They cannot legally transfer the company's value to themselves or "cancel" your stake to benefit themselves without facing massive legal liability (derivative lawsuits). Waitting ....
View on StockTwits ↗$AFIB who sold 12 cents worth of stock today!!? 😁😆😅🤣🤣 Better question is, given that retail can not buy, Who is sitting on the bid with over A million shares at .0002!!!!? And why!!? I want to see them file BK, The court trustee needs to Tell me to turn the lights off. Till then we play.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.